ClinicalTrials.govpublic full text
CAR-T Technology for Recurrent/Refractory Malignant Hematological and Lymphatic Tumors
car-t cell therapy, lymphomas, car-t therapy, recurrent/refractory malignant hematological lymphomas, interventional, phase1
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 839162
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.